Cargando…
In silico studies on stilbenolignan analogues as SARS-CoV-2 Mpro inhibitors
COVID-19, a new strain of coronavirus family, was identified at the end of 2019 in China. The COVID-19 virus spread rapidly all over the world. Scientists strive to find virus-specific antivirals for the treatment of COVID-19. The present study reports a molecular docking study of the stilbenolignan...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier B.V.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7983322/ https://www.ncbi.nlm.nih.gov/pubmed/33776065 http://dx.doi.org/10.1016/j.cplett.2021.138563 |